As of June 3, 2025, Adamas Pharmaceuticals Inc (ADMS) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Adamas Pharmaceuticals Inc's Graham Number
Over recent years, Adamas Pharmaceuticals Inc's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2020-12-31 | - |
| 2019-12-31 | 6.37 |
| 2018-12-31 | 10.21 |
| 2017-12-31 | 3.40 |
This fluctuation highlights how Adamas Pharmaceuticals Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Adamas Pharmaceuticals Inc's Graham Number to Peers
To better understand Adamas Pharmaceuticals Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Adamas Pharmaceuticals Inc (ADMS) | - |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| Sierra Oncology Inc (SRRA) | 18.52 |
Compared to its competitors, Adamas Pharmaceuticals Inc's Graham Number is difficult to compare due to insufficient data.